Open access
Aug 2026
DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression
DBF4B holds promise as both a prognostic biomarker and a novel therapeutic target for HCC after functional experiments demonstrated that silencing DBF4B markedly suppressed the proliferative and migratory capabilities of HCC cells.
Bing Dong, Pengju Xi, Guang-Xin Yang et al.
· Molecular Biology Reports · 0 citations